Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Varta, Rock Tech Lithium, Millennial Lithium - all signs point to growth

ON THE AUTHOR: Carsten Mainitz The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research. Most r...
Carsten Mainitz | March 23, 2021 |

Buzz on the Bullboards: The calm before another September rally?

It’s the last leg of what looks like an end-of-month rally as investors try to make the most of August’s losses. Traders are neck-deep into a data-heavy week from company fiscal reports that could chart the hike path for interest rates. ...
Jonathon Brown | August 31, 2023 |

S&P 500 Index Must Bounce Here Or Hold Your Breath!

The fragility of the markets can not be underestimated for investors at this time. Our research has continued to pick apart these price swings in the US stock markets and our July predictions regarding a market top and an August 19 th (or near) breakdown price move ...
Chris Vermeulen | August 26, 2019 |

Three Charts Every Trader and Investor Must See

Understanding the stock market and its potential through the use of technical analysis and historical price events has been proven repeatedly to outperform all forms of fundamental trading styles. The following is a story that walks you through my experience, the shift in my...
Chris Vermeulen | March 30, 2020 |

Fintech Payment Solutions Provided…Seamlessly

In mid-July , our Stockhouse audience was introduced to a fintech company with a very unique business model that’s created a secure, easy-to-use payment solution for the student market – Euro Asia Pay Holdings Inc. (EAP) ( CSE.EAP , Forum ). St...
Dave Jackson | September 21, 2021 |

Massive Price Reversion May Be Days or Weeks Away

Our researcher team believes a massive global market price reversion/correction may be setting up and may only be a few days or weeks away from initiating. Our team of dedicated researchers and market analysts have been studying the markets, precious metals, and most recently ...
Chris Vermeulen | September 23, 2019 |

Is Silver About To Become The Super-Hero Of Precious Metals?

If you've been following our research, you already know how accurately we've been nailing the precious metals price moves. We've been calling Gold and Silver accurately since early 2018 and continue to focus a good portion of our efforts in studying these incredible setups. Le...
Chris Vermeulen | September 24, 2019 |

Regeneron Reports Positive Phase 3 Dupixent Data; Gains EU Approval Recommendation

Regeneron Pharmaceuticals published positive results from two U.S. Phase 3 trials evaluating the safety and efficacy of Dupixent (dupilumab) in adults with recurring severe chronic rhinosinusitis with nasal polyps. The European Medicines Agency's Committee for Medicinal Produc...
Streetwise Reports | September 24, 2019 |

Shares Rise as The Medicines Company Reports Positive Topline Results...

Shares Rise as The Medicines Company Reports Positive Topline Results from Two Phase 3 Cholesterol Trials The Medicines Company's shares are trading 8.5% higher today after the firm reported positive results from two phase 3 studies for inclisiran, one for familial hype...
Streetwise Reports | September 26, 2019 |

Tax Loss Silly Season Whacks Viva Gold

Investors spend a lot of time pondering both Technical Analysis and fundamentals to determine entry and exit points for investing. Perhaps they would make more money studying human behavior. Investing is not as difficult as the Gurus and Experts try to make it; it is no...
Streetwise Reports | November 27, 2019 |
1 2 3 4 5